We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
-9.29%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$24.7B
AUM Growth
-$9.98B
(-29%)
Cap. Flow
-$5.49B
Cap. Flow
% of AUM
-22.2%
Top 10 Holdings %
Top 10 Hldgs %
40.01%
Holding
122
New
16
Increased
31
Reduced
30
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$645M |
| 2 |
Amazon
AMZN
|
+$447M |
| 3 |
International Flavors & Fragrances
IFF
|
+$436M |
| 4 |
XP
XP
|
+$295M |
| 5 |
Otis Worldwide
OTIS
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$1.4B |
| 2 |
Humana
HUM
|
+$1.24B |
| 3 |
Twilio
TWLO
|
+$785M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$659M |
| 5 |
GE Aerospace
GE
|
+$501M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.58% |
| 2 | Financials | 20.43% |
| 3 | Industrials | 13.4% |
| 4 | Technology | 13.29% |
| 5 | Communication Services | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Procept Biorobotics
PRCT
$1.23B
| $128M | 0.52% |
3,658,892
-1,249,000
| -25% | -$30.1M |
|
52
Booking.com
BKNG
$159B
| $127M | 0.51% |
1,355,850
-1,851,100
| -58% | -$173M |
|
|
KRTX
53
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $124M | 0.5% |
974,345
+110,681
| +13% | +$12.5M |
|
54
Progressive
PGR
$121B
| $118M | 0.48% |
+1,037,306
| New | +$112M |
|
|
INBX
55
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $118M | 0.48% |
5,305,866
| – | – |
|
56
PVH
PVH
$3.82B
| $118M | 0.48% |
1,542,375
+773,566
| +101% | +$71.6M |
|
57
Avantor
AVTR
$9.28B
| $117M | 0.47% |
3,459,963
-5,327,379
| -61% | -$190M |
|
|
BHVN
58
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $115M | 0.46% |
966,139
+617,356
| +177% | +$77M |
|
59
JD.com
JD
$42.2B
| $101M | 0.41% |
1,748,330
-2,017,591
| -54% | -$137M |
|
60
Perrigo
PRGO
$1.72B
| $97M | 0.39% |
+2,525,266
| New | +$96.1M |
|
61
MetLife
MET
$61.5B
| $95.7M | 0.39% |
+1,362,166
| New | +$92.1M |
|
62
Lithia Motors
LAD
$8.28B
| $95.1M | 0.38% |
316,904
-474,180
| -60% | -$148M |
|
63
Zentalis Pharmaceuticals
ZNTL
$299M
| $93.5M | 0.38% |
2,026,656
-91,628
| -4% | -$4.94M |
|
64
Amylyx Pharmaceuticals
AMLX
$2.66B
| $92.1M | 0.37% |
+7,170,536
| New | +$162M |
|
65
Take-Two Interactive
TTWO
$45.6B
| $90.5M | 0.37% |
588,443
-615,518
| -51% | -$98.5M |
|
66
Dollar General
DG
$26.4B
| $86.5M | 0.35% |
+388,317
| New | +$82.5M |
|
67
Inspire Medical Systems
INSP
$1.68B
| $79.8M | 0.32% |
+310,881
| New | +$71M |
|
68
Elevance Health
ELV
$85.8B
| $69.2M | 0.28% |
+140,895
| New | +$64.4M |
|
69
Blackstone
BX
$109B
| $64.7M | 0.26% |
+509,587
| New | +$62.2M |
|
70
Celldex Therapeutics
CLDX
$3.5B
| $62.9M | 0.25% |
1,846,647
+1,088,766
| +144% | +$34.8M |
|
|
XYZ
71
Block Inc
XYZ
$46.7B
| $61.2M | 0.25% |
451,534
-3,413
| -0.8% | -$413K |
|
72
4D Molecular Therapeutics
FDMT
$601M
| $59.5M | 0.24% |
3,937,914
| – | – |
|
73
Boeing
BA
$182B
| $58.5M | 0.24% |
+305,347
| New | +$61.3M |
|
74
Pharvaris
PHVS
$2.42B
| $46.4M | 0.19% |
2,480,319
+24,783
| +1% | +$437K |
|
|
FTCH
75
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $42.6M | 0.17% |
2,819,222
-3,126,874
| -53% | -$60.5M |
|
Similar funds
VIA
Viking Global Investors's Q1 2022 Portfolio in Review
As of Q1 2022, Viking Global Investors held 122 positions worth $24.7B, down 29% from $34.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Viking Global Investors withdrew a net $5.49B in Q1 2022, closing 31 positions and reducing 30 holdings. Its most notable exit was Humana, an estimated $1.24B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 37% a quarter earlier, followed by Financials and Industrials.
Against the trend, Viking Global Investors opened a new position in Mastercard worth $641M.
- Viking Global Investors's largest Q1 2022 buy was Mastercard: 1,793,488 shares worth $641M.
- Viking Global Investors added most to Amazon in Q1 2022, an estimated $447M increase.
- Viking Global Investors's biggest Q1 2022 reduction was Ginkgo Bioworks, cutting an estimated $1.4B.
- Viking Global Investors fully exited Humana in Q1 2022, selling an estimated $1.24B.
- Viking Global Investors's ten largest holdings make up 40% of its $24.7B portfolio in Q1 2022.
- Viking Global Investors opened 16 new positions and closed 31 in Q1 2022.
- Viking Global Investors's portfolio value fell 29% quarter-over-quarter to $24.7B.
Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.